Inventor · disambiguated record
Christiana I. Iwuagwu
Also filed as: IWUAGWU CHRISTIANA · IWUAGWU CHRISTIANA I
13 granted patents·19 pending applications·78 citations·filing 2006–2024
90Inventor score
Files withVIIV HEALTHCARE UK NO 5 LTD17BRISTOL MYERS SQUIBB CO8COOK II JAMES H3MCDONALD IVAR M2LENTZ KIMBERLEY A1
Top patents by PatentIndex Score
32 records- 0195US10869934B2Antiproliferative compounds and conjugates made therefromBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 22, 2020·8 cites·1 claims
- 0291US12129255B2Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2020·Granted Oct 29, 2024·2 cites·21 claims
- 0391US7863291B2Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jan 4, 2011·22 cites·14 claims
- 0490US10954252B1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Granted Mar 23, 2021·6 cites·11 claims
- 0589US10398783B2Antiproliferative compounds and conjugates made therefromBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 3, 2019·7 cites·4 claims
- 0687US8309577B2Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligandsCOOK II JAMES H·Filed 2009·Granted Nov 13, 2012·10 cites·18 claims
- 0786US11505543B24-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Nov 22, 2022·3 cites·4 claims
- 0877US8431695B2Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseasesO'CONNOR STEPHEN·Filed 2006·Granted Apr 30, 2013·5 cites·6 claims
- 0976US11919897B2Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Mar 5, 2024·1 cites·25 claims
- 1076US8507516B2Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Aug 13, 2013·4 cites·3 claims
- 1176US2025019383A1Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2024·Application pending·0 cites
- 1276US2024374598A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2024·Application pending·0 cites
- 1375US8278320B2Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligandsMCDONALD IVAR M·Filed 2010·Granted Oct 2, 2012·4 cites·14 claims
- 1474US8481555B2Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugsLENTZ KIMBERLEY A·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 1566US2015094309A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1665US2014221377A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1762US2013131064A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1861US2021379071A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
- 1958US2015342935A1Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligandsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2056US2012035178A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsCOOK II JAMES H·Filed 2011·Application pending·0 cites
- 2156US2012035189A1Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor LigandsCOOK II JAMES H·Filed 2011·Application pending·0 cites
- 2255US2023355626A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 2353US2023106880A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 2452US2022370451A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2020·Application pending·0 cites
- 2551US2022389007A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2020·Application pending·0 cites
- 2650US2022105096A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2020·Application pending·0 cites
- 2747US2021395262A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
- 2846US2022089598A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
- 2946US2021395248A1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Application pending·0 cites
- 3042US8841301B2Selective NR2B antagonistsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Sep 23, 2014·0 cites·10 claims
- 3141US2020016136A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 3240US2020055839A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christiana I. Iwuagwu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →